Literature DB >> 20538109

Comparison of outcomes among moderate alcohol drinkers before acute myocardial infarction to effect of continued versus discontinuing alcohol intake after the infarct.

Maia D Carter1, John H Lee, Donna M Buchanan, Eric D Peterson, Fengming Tang, Kimberly J Reid, John A Spertus, Josh Valtos, James H O'Keefe.   

Abstract

Light-to-moderate alcohol consumption has been previously associated with a lower risk of acute myocardial infarction (AMI) and mortality. The association of changes in drinking behavior after an AMI with health status and long-term outcomes is unknown. Using a prospective cohort of patients with AMI evaluated with the World Health Organization's Alcohol Use Disorders Identification Test, we investigated changes in drinking patterns in 325 patients who reported moderate drinking at the time of their AMI. One-year alcohol consumption, disease-specific (angina pectoris and quality of life) and general (mental and physical) health status and rehospitalization outcomes, and 3-year mortality were assessed. Seattle Angina Questionnaire Angina Frequency and Quality of Life, Short Form-12 Mental and Physical Component Summary Scales were modeled using multivariable hierarchical linear models within site. Of the initial 325 moderate drinkers at baseline, 273 (84%) remained drinking and 52 (16%) quit. In fully adjusted models, Physical Component Scale scores (beta 6.47, 95% confidence interval 3.73 to 9.21, p <0.01) were significantly higher during follow-up in those who remained drinking. Persistent moderate drinkers had a trend toward less angina (relative risk 0.65, 95% confidence interval 0.39 to 1.10, p = 0.11), fewer rehospitalizations (hazard ratio 0.79, 95% confidence interval 0.44 to 1.41, p = 0.42), lower 3-year mortality (relative risk 0.75, 95% confidence interval 0.23 to 2.51, p = 0.64), and better disease-specific quality of life (Seattle Angina Questionnaire Quality of Life, beta 3.88, 95% confidence interval -0.79 to 8.55, p = 0.10) and mental health (Mental Component Scale, beta 0.83, 95% confidence interval -1.62 to 3.27, p = 0.51) than quitters. In conclusion, these data suggest that there are no adverse effects for moderate drinkers to continue consuming alcohol and that they may have better physical functioning compared to those who quit drinking after an AMI.

Entities:  

Mesh:

Year:  2010        PMID: 20538109     DOI: 10.1016/j.amjcard.2010.01.339

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Long-term alcohol consumption in relation to all-cause and cardiovascular mortality among survivors of myocardial infarction: the Health Professionals Follow-up Study.

Authors:  Jennifer K Pai; Kenneth J Mukamal; Eric B Rimm
Journal:  Eur Heart J       Date:  2012-03-27       Impact factor: 29.983

Review 2.  Effect of Alcohol Consumption on Cardiovascular Health.

Authors:  Sunny Goel; Abhishek Sharma; Aakash Garg
Journal:  Curr Cardiol Rep       Date:  2018-03-08       Impact factor: 2.931

Review 3.  Alcohol use disorders and the heart.

Authors:  Ed Day; James H F Rudd
Journal:  Addiction       Date:  2019-07-15       Impact factor: 6.526

4.  Effect of Moderate Wine Consumption on Oxidative Stress Markers in Coronary Heart Disease Patients.

Authors:  Maria Choleva; Chrysa Argyrou; Maria Detopoulou; Maria-Eleni Donta; Anastasia Gerogianni; Evanggelia Moustou; Androniki Papaemmanouil; Christina Skitsa; Genovefa Kolovou; Petros Kalogeropoulos; Elizabeth Fragopoulou
Journal:  Nutrients       Date:  2022-03-25       Impact factor: 5.717

5.  Long-term change in alcohol-consumption status and variations in fibrinogen levels: the coronary artery risk development in young adults (CARDIA) study.

Authors:  Tochi M Okwuosa; Oana Klein; Cheeling Chan; Pamela Schreiner; Kiang Liu; David Green
Journal:  BMJ Open       Date:  2013-07-11       Impact factor: 2.692

6.  Multiple Risk Factors of Alcoholic and Non-Alcoholic Myocardial Infarction Patients.

Authors:  Awnish Kumar Singh; Nidhu Ram Dangal; Krishna Mohan Surapaneni; Ashish Joshi
Journal:  Glob J Health Sci       Date:  2015-05-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.